{"count":43797,"next":"https://cinder.proteo.info/api/ms_vocab/?format=json&limit=20&offset=12860&ordering=-name","previous":"https://cinder.proteo.info/api/ms_vocab/?format=json&limit=20&offset=12820&ordering=-name","results":[{"accession":"GO:0002573","name":"myeloid leukocyte differentiation","definition":"['The process in which a relatively unspecialized myeloid precursor cell acquires the specialized features of any cell of the myeloid leukocyte lineage.']","term_type":"cell line"},{"accession":"GO:0002274","name":"myeloid leukocyte activation","definition":"['A change in the morphology or behavior of a myeloid leukocyte resulting from exposure to an activating factor such as a cellular or soluble ligand.']","term_type":"cell line"},{"accession":"CL:0000766","name":"myeloid leukocyte","definition":"['A cell of the monocyte, granulocyte, or mast cell lineage.']","term_type":"cell line"},{"accession":"DOID:8692","name":"myeloid leukemia","definition":"['A leukemia that is located_in myeloid tissue.']","term_type":"cell line"},{"accession":"GO:0043011","name":"myeloid dendritic cell differentiation","definition":"['The process in which a monocyte acquires the specialized features of a dendritic cell, an immunocompetent cell of the lymphoid and hemopoietic systems and skin.']","term_type":"cell line"},{"accession":"GO:0001773","name":"myeloid dendritic cell activation","definition":"['The change in morphology and behavior of a dendritic cell resulting from exposure to a cytokine, chemokine, cellular ligand, or soluble factor.']","term_type":"cell line"},{"accession":"CL:0000782","name":"myeloid dendritic cell","definition":"['A dendritic cell of the myeloid lineage.', 'These cells are CD1a-negative, CD1b-positive, CD11a-positive, CD11c-positive, CD13-positive, CD14-negative, CD20-negative, CD21-negative, CD33-positive, CD40-negative, CD50-positive, CD54-positive, CD58-positive, CD68-negative, CD80-negative, CD83-negative, CD85j-positive, CD86-positive, CD89-negative, CD95-positive, CD120a-negative, CD120b-positive, CD123-negative, CD178-negative, CD206-negative, CD207-negative, CD209-negative, and TNF-alpha-negative. Upon TLR stimulation, they are capable of producing high levels of TNF-alpha, IL-6, CXCL8 (IL-8).']","term_type":"cell line"},{"accession":"GO:0002262","name":"myeloid cell homeostasis","definition":"['The process of regulating the proliferation and elimination of myeloid cells such that the total number of myeloid cells within a whole or part of an organism is stable over time in the absence of an outside stimulus.']","term_type":"cell line"},{"accession":"GO:0030099","name":"myeloid cell differentiation","definition":"['The process in which a relatively unspecialized myeloid precursor cell acquires the specialized features of any cell of the myeloid leukocyte, megakaryocyte, thrombocyte, or erythrocyte lineages.']","term_type":"cell line"},{"accession":"CL:0000763","name":"myeloid cell","definition":"['A cell of the monocyte, granulocyte, mast cell, megakaryocyte, or erythroid lineage.']","term_type":"cell line"},{"accession":"CL:0000835","name":"myeloblast","definition":"['The most primitive precursor in the granulocytic series, having fine, evenly distributed chromatin, several nucleoli, a high nuclear-to-cytoplasmic ration (5:1-7:1), and a nongranular basophilic cytoplasm. They reside in the bone marrow.']","term_type":"cell line"},{"accession":"CL:0000218","name":"myelinating Schwann cell","definition":"['A neuroglial cell of the peripheral nervous system which forms the insulating myelin sheaths of peripheral axons.']","term_type":"cell line"},{"accession":"CL:0000328","name":"myelin accumulating cell","definition":"[]","term_type":"cell line"},{"accession":"UBERON:0005290","name":"myelencephalon","definition":"['The posterior part of the developing vertebrate hindbrain or the corresponding part of the adult brain composed of the medulla oblongata and a portion of the fourth ventricle; as well as the glossopharyngeal nerve (CN IX), vagus nerve (CN X), accessory nerve (CN XI), hypoglossal nerve (CN XII), and a portion of the vestibulocochlear nerve (CN VIII).[BTO,WP].']","term_type":"cell line"},{"accession":"CLO:0007917","name":"MYC CT 9-B7.3 cell","definition":"['disease: hybridoma']","term_type":"cell line"},{"accession":"CLO:0007916","name":"MYC CT 14-G4.3 cell","definition":"['disease: hybridoma']","term_type":"cell line"},{"accession":"CLO:0007915","name":"MYC 1-9E10.2 cell","definition":"['disease: hybridoma']","term_type":"cell line"},{"accession":"CLO:0007914","name":"MYB 2-7.77 cell","definition":"['disease: hybridoma']","term_type":"cell line"},{"accession":"CLO:0007913","name":"MYB 2-3.76 cell","definition":"['disease: hybridoma']","term_type":"cell line"},{"accession":"DOID:437","name":"myasthenia gravis","definition":"[]","term_type":"cell line"}]}